Loading...

No results found

Header image

Stephenson Harwood advises BenevolentAI on strategic collaboration with Merck

Life Sciences & Healthcare | 20/09/2023

Law firm Stephenson Harwood LLP has advised BenevolentAI on its recent strategic collaboration with Merck.

The collaboration will use BenevolentAI’s end-to-end AI platform capabilities to deliver novel drug candidates – initially for three targets in oncology, neurology and immunology – and to identify and develop innovative compounds through Hit Identification to pre-clinical stage. Under the terms of the agreement, BenevolentAI will be eligible for payments of up to $594 million, consisting of a low double-digit million dollar upfront payment on signing and then potentially discovery, development and commercial milestones. Tiered royalties will also be payable on net sales of any commercialised products.

BenevolentAI, a Euronext Amsterdam-listed company headquartered in London, is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery. Merck is a science and technology company headquartered in Darmstadt, Germany.

The Stephenson Harwood team was led by head of life sciences and partner Alexandra Pygall, who was supported by managing associate Anne Stoffels, associate Ainsleigh Stone and corporate tax partner Shofiq Miah.

Share Article

Share on Linkedin Share on Bluesky

Related Expertise

Life Sciences & Healthcare Corporate

Contributors

Miah Shofiq (1)

Shofiq Miah

Partner

London

Pygall Alexandra

Alexandra Pygall

Partner - Head of Intellectual Property, London & Head of Life Sciences & Healthcare sector

London

Related Articles

Adobestock 800215882

Life Sciences A to Z - S is for Safe Harbour: What you need to know about the UK's new Technology Transfer Block Exemption

Life Sciences & Healthcare
Adobestock 312508645

Life Sciences A to Z - R is for Rare Diseases in the UK: An Overview of the Regulatory and Policy Landscape

Life Sciences & Healthcare
Insights Orange Mushroom Gills Adobestock 137390679 OVERLAY

Partner Paul Inman joins Stephenson Harwood

Life Sciences & Healthcare
Lifesciences Istock 1181631890 Test Tube Dropper Droplet

Media coverage: Private clinics and hospitals in difficulty - what risks, good practices, and opportunities?

Restructuring & Insolvency